
    
      OBJECTIVES:

        -  To examine serum samples from patients with head and neck cancer or advanced colorectal
           cancer previously treated with cetuximab for the presence of antibodies against
           cetuximab.

      OUTLINE: Serum samples are examined by immunoreactivity screening of IgE, IgG, IgA, and IgM
      antibodies and complement reaction.
    
  